FDA.reportPublic FDA data

tripelennamine hydrochloride 0.005 MG/MG

RxCUI
1294613
RxNorm name
tripelennamine hydrochloride 0.005 MG/MG
Term type
SCDC
Status
Active
Updated
2026-07-26 06:56:51

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062012
Active start
062012
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
0.005 MG / 1 MGtripelennamine

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
tripelennamine10847

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRtripelennamine hydrochloride 0.005 MG/MG1NAMES
RxNorm Nametripelennamine hydrochloride 0.005 MG/MG1NAMES
TTYSCDC1ATTRIBUTES
RxCUI12946131CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04AAAntihistamines for topical useATC1-4tripelennamine
ATCR06ACSubstituted ethylene diaminesATC1-4tripelennamine
MEDRTD014309TripelennamineCHEMhas_ingredienttripelennamine hydrochloride
MEDRTD014309TripelennamineCHEMhas_ingredienttripelennamine
MEDRTD001249AsthmaDISEASEmay_treattripelennamine
MEDRTD001249AsthmaDISEASEmay_treattripelennamine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withtripelennamine
MEDRTD004342Drug HypersensitivityDISEASEci_withtripelennamine hydrochloride
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withtripelennamine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withtripelennamine hydrochloride
MEDRTD007223InfantDISEASEci_withtripelennamine
MEDRTD007223InfantDISEASEci_withtripelennamine hydrochloride
MEDRTD007774LactationDISEASEci_withtripelennamine
MEDRTD007774LactationDISEASEci_withtripelennamine hydrochloride
MEDRTD010437Peptic UlcerDISEASEci_withtripelennamine
MEDRTD010437Peptic UlcerDISEASEci_withtripelennamine hydrochloride
MEDRTD011470Prostatic HyperplasiaDISEASEci_withtripelennamine
MEDRTD011470Prostatic HyperplasiaDISEASEci_withtripelennamine hydrochloride
MEDRTD012140Respiratory Tract DiseasesDISEASEci_withtripelennamine
MEDRTD012140Respiratory Tract DiseasesDISEASEci_withtripelennamine hydrochloride
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattripelennamine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattripelennamine hydrochloride
MEDRTD001748Urinary Bladder Neck ObstructionDISEASEci_withtripelennamine
MEDRTD001748Urinary Bladder Neck ObstructionDISEASEci_withtripelennamine hydrochloride
MEDRTD014581UrticariaDISEASEmay_treattripelennamine hydrochloride
MEDRTD014581UrticariaDISEASEmay_treattripelennamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moatripelennamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moatripelennamine hydrochloride
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moatripelennamine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moatripelennamine hydrochloride
MEDRTN0000008657Decreased Histamine ActivityPEhas_petripelennamine
MEDRTN0000008657Decreased Histamine ActivityPEhas_petripelennamine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYHYBRID
ATTRIBUTESIN_EXPRESSED_FLAGP
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSTRENGTH0.005 MG/MG